Israeli artificial intelligence startup Inflowz has completed its seed funding round, securing $3.5 million from Israeli venture capital firm Glilot Capital Partners.
Read more on NoCamels here.
![[CytoReason in The Times of Israel] Swiss pharma firm Ferring, Israel’s CytoReason join to battle bowel disease](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[CytoReason in The Times of Israel] Swiss pharma firm Ferring, Israel’s CytoReason join to battle bowel disease
May 19, 2021
[Kenna Security in The Fintech Times] Kenna Security: FinServ’s Newfound Appreciation for Cybersecurity Teams
January 31, 2021
